31 research outputs found
Recommended from our members
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
Objective: To characterise the trends in the left ventricular assist device (LVAD) implantation rates and outcomes between 2004 and 2011 in the Medicare population. Since the approval of the HeartMate II in 2008, the use of LVADs has steadily climbed. Given the increase in LVAD use, issues around discharge disposition, post-implant hospitalisations and costs require further understanding. Methods: We examined LVAD implantation rates and short-term and long-term outcomes among Medicare fee-for-service beneficiaries hospitalised for LVAD implantation. We also conducted analyses among survivors 1-year post-discharge to examine rehospitalisation rates. Lastly, we reported Centers for Medicare & Medicaid Services (CMS) payments for both index hospitalisation and rehospitalisations 1 year post-discharge. Results: A total of 2152 LVAD implantations were performed with numbers increasing from 107 in 2004 to 612 in 2011. The 30-day mortality rate decreased from 52% to 9%, and 1-year mortality rate decreased from 69% to 31%. We observed no change in overall length of stay, but post-procedure length of stay increased. We also found an increase in home discharge dispositions from 26% to 53%. Between 2004 and 2010, the rehospitalisation rate increased and the number of hospital days decreased. The adjusted CMS payment for the index hospitalisation increased from 225 697 over time but decreased for rehospitalisation from 53 630. Conclusions: LVAD implantations increased over time. We found decreasing 30-day and 1-year mortality rates and increasing home discharge disposition. The proportion of patients rehospitalised among 1-year survivors remained high with increasing index hospitalisation cost, but decreasing post-implantation costs over time
Growth or somatotrophic hormone: new perspectives in isolated GH deficiency after description of the mutation in the GHRH receptor gene in individuals of Itabaianinha county, Brazil
Além de influenciar o crescimento corpóreo, o hormônio do crescimento,
ou somatotrófico, desempenha importante papel no metabolismo,
composição corporal, perfil lipídico, estado cardiovascular e
longevidade. Seu controle é multi-regulado por hormônios, metabólitos
e peptídeos hipotalâmicos. Dados sobre a Deficiência Isolada de GH
(DIGH) obtidos a partir da descrição da mutação IVS1+1G→A no gene
do receptor do hormônio liberador do GH (GHRH-R) em indivíduos da
cidade de Itabaianinha, SE, são revisados. São abordadas novas perspectivas
sobre o modelo de resistência ao GHRH, a importância do
GHRH no controle da secreção de GH, a freqüência das mutações do
gene do GHRH-R, a relevância diagnóstica do IGF-I e os achados
metabólicos, cardiovasculares e de qualidade de vida nestes indivíduos._________________________________________________________________________________________ ABSTRACT: In addition to stimulating body growth, growth or somatotrophic hormone
plays an important role in metabolism, body composition, lipid
profile, cardiovascular status and longevity. Its control is multiregulated
by hormones, metabolites and hypothalamic peptides. Obtained data
of the isolated growth hormone deficiency (IGHD) after the description
of the IVS1+1G→A GHRH receptor gene mutation in individuals of Itabaianinha
County are reviewed. New perspectives about the growth hormone
resistance model, the importance of GHRH in the control of GH
secretion, the frequency of GHRH-R gene mutations, the diagnostic relevance
of IGF-I and the metabolic, cardiovascular and quality of life findings
are approached
2 nd Brazilian Consensus on Chagas Disease, 2015
Abstract Chagas disease is a neglected chronic condition with a high burden of morbidity and mortality. It has considerable psychological, social, and economic impacts. The disease represents a significant public health issue in Brazil, with different regional patterns. This document presents the evidence that resulted in the Brazilian Consensus on Chagas Disease. The objective was to review and standardize strategies for diagnosis, treatment, prevention, and control of Chagas disease in the country, based on the available scientific evidence. The consensus is based on the articulation and strategic contribution of renowned Brazilian experts with knowledge and experience on various aspects of the disease. It is the result of a close collaboration between the Brazilian Society of Tropical Medicine and the Ministry of Health. It is hoped that this document will strengthen the development of integrated actions against Chagas disease in the country, focusing on epidemiology, management, comprehensive care (including families and communities), communication, information, education, and research
Pervasive gaps in Amazonian ecological research
Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear un derstanding of how ecological communities respond to environmental change across time and space.3,4
While the increasing availability of global databases on ecological communities has advanced our knowledge
of biodiversity sensitivity to environmental changes,5–7 vast areas of the tropics remain understudied.8–11 In
the American tropics, Amazonia stands out as the world’s most diverse rainforest and the primary source of
Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepre sented in biodiversity databases.13–15 To worsen this situation, human-induced modifications16,17 may elim inate pieces of the Amazon’s biodiversity puzzle before we can use them to understand how ecological com munities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus
crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced
environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple or ganism groups in a machine learning model framework to map the research probability across the Brazilian
Amazonia, while identifying the region’s vulnerability to environmental change. 15%–18% of the most ne glected areas in ecological research are expected to experience severe climate or land use changes by
2050. This means that unless we take immediate action, we will not be able to establish their current status,
much less monitor how it is changing and what is being lostinfo:eu-repo/semantics/publishedVersio
ATLANTIC-PRIMATES: a dataset of communities and occurrences of primates in the Atlantic Forests of South America
Primates play an important role in ecosystem functioning and offer critical insights into human evolution, biology, behavior, and emerging infectious diseases. There are 26 primate species in the Atlantic Forests of South America, 19 of them endemic. We compiled a dataset of 5,472 georeferenced locations of 26 native and 1 introduced primate species, as hybrids in the genera Callithrix and Alouatta. The dataset includes 700 primate communities, 8,121 single species occurrences and 714 estimates of primate population sizes, covering most natural forest types of the tropical and subtropical Atlantic Forest of Brazil, Paraguay and Argentina and some other biomes. On average, primate communities of the Atlantic Forest harbor 2 ± 1 species (range = 1–6). However, about 40% of primate communities contain only one species. Alouatta guariba (N = 2,188 records) and Sapajus nigritus (N = 1,127) were the species with the most records. Callicebus barbarabrownae (N = 35), Leontopithecus caissara (N = 38), and Sapajus libidinosus (N = 41) were the species with the least records. Recorded primate densities varied from 0.004 individuals/km 2 (Alouatta guariba at Fragmento do Bugre, Paraná, Brazil) to 400 individuals/km 2 (Alouatta caraya in Santiago, Rio Grande do Sul, Brazil). Our dataset reflects disparity between the numerous primate census conducted in the Atlantic Forest, in contrast to the scarcity of estimates of population sizes and densities. With these data, researchers can develop different macroecological and regional level studies, focusing on communities, populations, species co-occurrence and distribution patterns. Moreover, the data can also be used to assess the consequences of fragmentation, defaunation, and disease outbreaks on different ecological processes, such as trophic cascades, species invasion or extinction, and community dynamics. There are no copyright restrictions. Please cite this Data Paper when the data are used in publications. We also request that researchers and teachers inform us of how they are using the data. © 2018 by the The Authors. Ecology © 2018 The Ecological Society of Americ
Pervasive gaps in Amazonian ecological research
Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5,6,7 vast areas of the tropics remain understudied.8,9,10,11 In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepresented in biodiversity databases.13,14,15 To worsen this situation, human-induced modifications16,17 may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost
Pervasive gaps in Amazonian ecological research
Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5,6,7 vast areas of the tropics remain understudied.8,9,10,11 In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepresented in biodiversity databases.13,14,15 To worsen this situation, human-induced modifications16,17 may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost
Evaluation of the antidiabetic potential of five medicinal plants in rats
O presente estudo investigou o potencial antidiabético de extratos aquosos de cinco plantas medicinais indicadas popularmente para o tratamento do diabetes. Foram avaliados os efeitos anti-hiperglicemiantes agudos da metformina (500 mg/kg) e dos extratos da entrecasca de Bowdichia virgilioides Kunth (EABV), das folhas de Costus spicatus Swartz (EACS), das folhas de Chrysobalanus icaco L. (EACI), da entrecasca de Bumelia sartorum Mart (EABS) e da casca de Caesalpinia ferrea Mart (EACF) administrados em doses únicas de 200 mg/kg no teste oral de tolerância à glicose em ratos normoglicêmicos. Neste teste, somente o EABV, EACF e a metformina foram capazes de promover uma inibição da hiperglicemia induzida por sobrecarga de glicose em até 46,5, 51,7 e 48,3%, respectivamente. Estes resultados demonstram que das cinco espécies estudadas, duas apresentaram efeitos anti-hiperglicemiantes significativos que pode indicar uma possível ação antidiabética, o que reforça o indicativo popular.Potential antidiabetic activity of five medicinal plants indicated to diabetes was evaluated in normoglicemic rats. Metformin (500 mg/kg) and aqueous extract of Bowdichia virgilioides Kunth (EABV), Costus spicatus Swartz (EACS), Chrysobalanus icaco L. (EACI), Bumelia sartorum Mart (EABS) and Caesalpinia ferrea Mart (EACF), in a single dose of 200 mg/kg, were tested on the curve of glucose tolerance oral test. In this test, only metformina, EABV and EACF were able to inhibit the glucose-induced hyperglycemia up to 46.5, 51.7 e 48.3%, respectively. In conclusion, of the five plants tested, two plants showed anti-hyperglycemic effect that can indicate possible antidiabetic action, in according with popular use.Colegio de Farmacéuticos de la Provincia de Buenos Aire